# Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Source: https://onco.cc/trials/nct03949283/  
OnCo record `nct03949283` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Standard Chemotherapy in ovarian cancer, run by Cordgenics, LLC, active and no longer recruiting.

## Summary

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer is a phase 3 interventional study registered as NCT03949283 by Cordgenics, LLC, with 150 participants enrolled, started 2019-07-26 and due to reach its primary completion in 2024-06-30. Interventions recorded: Standard Chemotherapy.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03949283
- Phase: 3
- Setting: Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
- Sponsor: Cordgenics, LLC
- Enrolled: 150

## Sources

- ClinicalTrials.gov NCT03949283: https://clinicaltrials.gov/study/NCT03949283

## Connected records

- cancers: [Ovarian cancer](https://onco.cc/cancers/ovarian/)

---
JSON: https://onco.cc/api/v1/entities/nct03949283.json